Paydirt
AM
Insider

Adam Morgan

Director

Adam Morgan (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in HRTX. Across 1 priced purchase filing, the average 21-session return was -9.7% from execution and -1.6% from disclosure (delay-adjusted; derived). The largest single filing was $2.6M of HRTX (1,766,546 sh × $1.50, as filed), executed Aug 8 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
-9.7%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-1.6%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.6M
shares × price, as filed
Last traded
Aug 8 2025
Filed Aug 12 2025
Open performance→
Volume by month
$2.6M$1.3M$0Oct 2024Apr 2025Oct 2025Apr 2026Aug 2025 · buys $2.6M
Buys $2.6M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 24 months

Most traded names
HRTX HRTX HRTX · 1 buy · 0 sells 1 filing
Recent filings
HRTXPURCHASE HERON THERAPEUTICS, INC. /DE/ View filing → $2.6M
1,766,546 sh × $1.50
Exec Aug 8 2025
Filed Aug 12 2025 · 5:02 PM ET